Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a text message help young cancer survivors kick the vape habit?

NCT ID NCT05967585

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 37 times

Summary

This study looks at e-cigarette use among 500 teenage and young adult cancer survivors and tests a text-message based program to help them quit. Researchers will also interview patients and healthcare providers to find the best ways to offer this support in oncology clinics. The goal is to understand vaping behaviors and develop practical tools for quitting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VAPING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

text-message based vaping cessation program (This is Quitting)

What this could lead to

If successful, this could provide an effective, scalable way to help young cancer survivors quit vaping, improving their long-term health.

What could go wrong

This is an early implementation study, not a large efficacy trial. The program may not work well for all survivors, and results may not apply to other groups.

Conditions

The condition(s) this trial relates to.

cancer central nervous system neoplasm Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.